Literature DB >> 2670729

Immunohistochemical detection of the c-erbB-2 proto-oncogene product in normal, benign and malignant cartilage tissues.

F Wrba1, W J Gullick, H Fertl, G Amann, M Salzer-Kuntschik.   

Abstract

Benign and malignant cartilage tumours as well as normal cartilage were stained immunohistochemically with antibodies raised to a synthetic peptide from the sequence of the c-erbB-2 protein. Positive staining was present in 18/23 of the chondrosarcomas and in one case of osteochondroma. Normal and benign neoplastic cartilage tissues revealed negative results. It is concluded that expression of the c-erbB-2 protein may contribute to cell transformation in chondrosarcomas; it is not apparent whether the expression of c-erbB-2 protein in chondrosarcomas characterizes a subpopulation of different prognostic significance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670729     DOI: 10.1111/j.1365-2559.1989.tb03042.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  4 in total

1.  Chondrosarcomatous differentiation in diffuse-type gastric carcinoma.

Authors:  Vincenzo Villanacci; Marco Gambarotti; Alessandro Ubiali; Giancarlo Cervi; Giuseppe Pulcini; Vittorio De Cesare; Gabrio Bassotti
Journal:  Dig Dis Sci       Date:  2006-08-22       Impact factor: 3.199

Review 2.  Molecular pathology of chondroid neoplasms: part 2, malignant lesions.

Authors:  W C Bell; M J Klein; M J Pitt; G P Siegal
Journal:  Skeletal Radiol       Date:  2006-10-18       Impact factor: 2.199

3.  C-erbB-2 immunostaining: problems with interpretation.

Authors:  E W Kay; C J Walsh; M Cassidy; B Curran; M Leader
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

4.  Immunohistochemistry as an important tool in biomarkers detection and clinical practice.

Authors:  Leandro Luongo de Matos; Damila Cristina Trufelli; Maria Graciela Luongo de Matos; Maria Aparecida da Silva Pinhal
Journal:  Biomark Insights       Date:  2010-02-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.